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Raswas found to regulateDictyostelium chemotaxis,
but the mechanisms that spatially and temporally
control Ras activity during chemotaxis remain largely
unknown. We report the discovery of a Ras signaling
complex that includes the Ras guanine exchange
factor (RasGEF) Aimless, RasGEFH, protein phos-
phatase 2A (PP2A), and a scaffold designated
Sca1. The Sca1/RasGEF/PP2A complex is recruited
to the plasma membrane in a chemoattractant- and
F-actin-dependent manner and is enriched at the
leading edge of chemotaxing cells where it regulates
F-actin dynamics and signal relay by controlling the
activation of RasC and the downstream target of ra-
pamycin complex 2 (TORC2)-Akt/protein kinase B
(PKB) pathway. In addition, PKB and PKB-related
PKBR1 phosphorylate Sca1 and regulate the
membrane localization of the Sca1/RasGEF/PP2A
complex, and thereby RasC activity, in a negative
feedback fashion. Thus, our study uncovered
a molecular mechanism whereby RasC activity and
the spatiotemporal activation of TORC2 are tightly
controlled at the leading edge of chemotaxing cells.
INTRODUCTION
Chemotaxis, the guided movement of cells in response to
external cues or chemoattractants, is central to numerous bio-
logical processes, including embryogenesis, the immune
response, and metastasis of tumor cells. Chemotaxis is equally
central to the life cycle of Dictyostelium, allowing the free-living
amoebae to chase bacteria, their food source, as well as to
aggregate and form multicellular structures upon starvation
(Annesley and Fisher, 2009). Aggregation of Dictyostelium cells
is driven by their ability to respond to the chemoattractant
cAMP and to relay the signal through chemoattractant-induced
activation of adenylyl cyclase A (ACA) and the subsequent secre-
tion of cAMP in an oscillatory fashion (signal relay).
Studies over the past few years have uncovered key signaling
pathways involved in the chemotactic response of amoeboid
cells, such as Dictyostelium and neutrophils, and have shed lightDeveon the spatial and temporal regulation of these pathways, which
is required for cells to perform efficient chemotaxis. Ras proteins
play major roles in the control of Dictyostelium chemotaxis. Ras
activation is the earliest known response to chemoattractant
stimulation downstream from the receptors and heterotrimeric
G proteins, and active Ras is enriched at the leading edge of che-
motaxing cells (Sasaki et al., 2004). TwoDictyostelium homologs
of human H-Ras, RasC and RasG, control cell motility, chemo-
taxis, and signal relay, acting in part through the regulation of
phosphatidyl-inositol 3-kinase (PI3K) and target of rapamycin
complex 2 (TORC2), two known regulators of Akt/protein kinase
B (PKB) (Bolourani et al., 2006; Funamoto et al., 2002; Kamimura
et al., 2008; Lee et al., 1999, 2005; Lim et al., 2001; Meili et al.,
1999; Sasaki and Firtel, 2006; Sasaki et al., 2007). The recent
findings that Ras is an important regulator of PI3Kg signaling in
migrating neutrophils and that human Sin1, a component of
mammalian TORC2 and the ortholog of Dictyostelium Ras inter-
acting protein 3 (RIP3), binds activated H- and K-Ras suggest
that the role of Ras in directed cell migration may be conserved
in mammalian cells (Schroder et al., 2007; Suire et al., 2006). In
Dictyostelium, the site of Ras activation directly determines the
site of PI3K activation and PI(3,4,5)P3 production, which then
helps guide the local polymerization of F-actin and pseudopod
extension (Affolter and Weijer, 2005; Huang et al., 2003; Para
et al., 2009; Sasaki et al., 2004; Zhang et al., 2008). TORC2 is
also an important regulator of Dictyostelium chemotaxis,
controlling cell polarity and motility, as well as signal relay,
through regulation of the cytoskeleton and ACA activity, respec-
tively (Kamimura et al., 2008; Lee et al., 2005). In addition, recent
observations suggest that TORC2 activity is spatially regulated
at the leading edge ofmigrating cells, causing the local activation
of PKB and PKB-related PKBR1 (Kamimura et al., 2008). While
RasC and RasG appear to be partially redundant, evidence
suggests that signal transduction through RasC is more impor-
tant for ACA activation, whereas RasG plays a more important
role in PI3K activation; and disruption of both RasC and RasG
signaling results in cells that exhibit severe polarity and direc-
tional sensing defects (Bolourani et al., 2006; Sasaki et al.,
2004; Zhang et al., 2008).
Several years ago, aDictyostelium homolog of themammalian
Ras guanine exchange factor (RasGEF) SOS, Aimless/Ras-
GEFA, was found to play an important role in the transduction
of chemotactic signals (Insall et al., 1996; Lee et al., 1999).
Subsequent studies suggest that Aimless is the major RasGEF
mediating the chemoattractant-induced activation of RasC,lopmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier Inc. 737
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(Kae et al., 2007). The present study was undertaken to identify
regulators of Ras signaling during Dictyostelium chemotaxis
and to better understand the mechanisms implicated in the
spatiotemporal control of Ras activity. Using a proteomic
approach, we identified a multimeric protein complex that
includes Aimless, RasGEFH, PHR, and protein phosphatase
2A (PP2A), assembled by the scaffold protein Sca1. We demon-
strate that this Ras signaling complex regulates the
RasC-TORC2-Akt/PKB pathway at the leading edge of chemo-
taxing cells and undergoes TORC2- and Akt/PKB-dependent
negative feedback regulation.
RESULTS
Aimless Is Part of a Stable Protein Complex
To study the molecular mechanisms that regulate Ras
signaling during chemotaxis, we took a proteomic approach
to identify proteins interacting with the RasGEF Aimless. We
expressed His/HA/FLAG (HHF)-tagged Aimless in gefA
(aimless null, aleA) cells and performed a sequential FLAG-
His affinity purification. Several proteins copurified with
Aimless in both vegetative and developed cells and the profile
of the pulled down proteins did not change upon cAMP stim-
ulation of developed cells, suggesting their interaction with
Aimless is not modulated by chemoattractant stimulation
(Figure 1A). Mass spectrometry analysis allowed identification
of the Aimless-interacting proteins: another RasGEF, Ras-
GEFH; the structural A subunit of PP2A (PP2A-A, gene:
pppA) and a putative catalytic C subunit we named PP2A-
C2 (gene: pho2B); an uncharacterized 174.9 kDa protein we
named Sca1; and a 111.6 kDa protein that contains a pleck-
strin homology domain as well as a Ras GTPase-related
domain we named PHR (Figure 1A; see Table S1 available
online). Although these proteins were found to be the most
abundant, additional proteins were identified in the Aimless
pull-down, most of which are proteins associated with the
protein synthesis, folding, or degradation machineries and
thus are less likely to represent interactions required for Ras-
GEF function (Table S1). Aimless and RasGEFH are very
similar and both display a Lissencephaly 1 (Lis1) homology
motif (LisH), a putative dimerization domain (Gerlitz et al.,
2005; Mateja et al., 2006). PP2A-A and -C2 most likely form
a core PP2A dimer as PP2A holoenzymes typically contain
a structural A and a catalytic C subunit, constituting an enzy-
matic core dimer that associates with a third, variable regula-
tory B subunit (Janssens et al., 2008). Interestingly, the gene
encoding Sca1 (scaA) was identified previously in a screen
for developmentally essential genes required for aggregation
(DG1105; dictyBase).
To assess whether Aimless interacts with each of the pulled
down proteins independently or if the proteins are in a large mul-
timeric complex, we analyzed and compared pull-downs per-
formed with individually epitope-tagged Aimless, RasGEFH, or
Sca1, each expressed in their respective null background. As
shown in Figure 1B and Figure S1A, all three proteins pull
down each other, as well as PHR and PP2A-A/C2, suggesting
Aimless, RasGEFH, Sca1, PHR, and PP2A-A/C2 form a single,
stable protein complex. RasGEFH and PHR are absent from738 Developmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier Ina pull-down performed with Aimless when Aimless’ LisH domain
is mutated (AimlessLisH; two conserved residues found to stabi-
lize LisH domain homodimerization in human Lis1), suggesting
that the presence of these two proteins in the complex requires
interaction with Aimless’ LisH domain (Figure 1B; Figure S1A).
To confirm the pull-down data and better understand the
structure of the complex, we assessed the interaction between
the different components by coimmunoprecipitation. As shown
in Figures 1C and 1D, Aimless and RasGEFH coimmunoprecipi-
tate each other, even in the absence of Sca1, but mutation of the
LisH domain in either one of the RasGEFs prevents their copur-
ification. In contrast, we never observed any coimmunoprecipi-
tation of two differentially tagged RasGEFHs or two differentially
tagged Aimless proteins (Figure 1E). These findings suggest
that Aimless and RasGEFH directly interact through their LisH
domain, forming an exclusive heterodimer. Because Aimless
and RasGEFH appear to directly interact through their LisH
domain, and an AimlessLisH mutant fails to pull down PHR in
addition to RasGEFH, we suggest PHR interacts directly with
RasGEFH.
We then tested the interaction of Sca1 with the RasGEFs and
PP2A. As shown in Figure 1F, Aimless and Sca1 coimmunopre-
cipitate each other, independently of Aimless’ LisH domain and
RasGEFH. In addition, although RasGEFH and Sca1 were found
to coimmunoprecipitate, they did not do so in the absence of
Aimless, consistent with the interaction between RasGEFH and
Sca1 being indirect, most likely through Aimless (Figure 1G).
Finally, we determined that Sca1 and PP2A-A coimmunoprecipi-
tate each other, even in the absence of both RasGEFs
(Figure 1H). To further investigate the molecular architecture of
the complex, we generated a series of Sca1 deletion mutants
and assessed their interaction with the other components in
pull-down assays (Figure 1I). As shown in Figure 1J and
Figure S1B, deletion of residues 401–600 (Sca1D2) results in
the complete loss of interaction of the RasGEFs, but not PP2A,
with Sca1, whereas mutants with deletions between residues
600 and 1400 (Sca1D3–D6) affect the interaction of Sca1 with
PP2A. Although some PP2A was detected in pull-downs with
Sca1D3 andD4, Sca1D5 andD6 appear to completely lose inter-
action with PP2A, while interaction with the RasGEFs is normal.
Altogether, these findings suggest that Sca1 acts as a molecular
scaffold, bringing together the RasGEFs and PHR with PP2A
(Figure 1K).
The Sca1 Complex Regulates Cell Motility, Chemotaxis,
and Signal Relay
To determine the biological function of the Sca1 complex,
we analyzed the phenotypes of mutant strains in which the
different components of the complex were disrupted either
alone or in combination. As shown in Figure 2A and Figure S2A,
the analysis of the developmental phenotypes of cells lacking
PHR, RasGEFH, Aimless, or Sca1 reveals that whereas the
development of phr and gefH cells is slightly delayed com-
pared to that of wild-type cells, cells lacking Aimless, both
RasGEFs, or Sca1 display severely impaired aggregation. Inter-
estingly, although expression of full-length Sca1 complements
the scaA cells’ developmental phenotype, expression of
the Sca1D2 deletion mutant, which fails to interact with the
RasGEFs, the mutants that most severely disrupt the interactionc.
Figure 1. Aimless Is Found in a Preformed Complex Assembled by the Scaffold Protein Sca1
(A and B) Silver staining of the SDS-PAGE-resolved proteins pulled down with HHF-Aimless, -AimlessLisH, -RasGEFH, or -Sca1, expressed in their respective null
background, from either vegetative (V) or developed cells stimulated or not with 1 mM cAMP for the time indicated. Wild-type cells (WT; AX2) were used as
controls. The most abundant purified proteins identified by mass spectrometry and their molecular mass are indicated. Aimless (70.7 kDa) and RasGEFH
(69.7 kDa) normally migrate at a similar molecular mass; addition of the HHF tag underlies the observable shifts (HHF-Aimless, 73.7 kDa; HHF-RasGEFH,
72.7 kDa). See also Table S1 and Figure S1A.
(C–H) HHF- or V5-tagged Aimless (HHF-Aim and V5-Aim) and RasGEFH (HHF-GEFH and V5-GEFH), their LisH domain mutant forms [AimLisH, Aimless (L79E,
E94A); GEFHLisH, RasGEFH (F127R, E142A)], and myc-Sca1 and T7-PP2A-A were assessed for interaction in coimmunoprecipitation (IP) and detected by
immunoblotting (IB).
(I) Sca1 deletion mutants.
(J) Pull-downs performed with the Sca1 deletion mutants compared to full-length Sca1. See also Figure S1B.
(K) Deduced architecture of the complex. Data are representative of at least two independent experiments.
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Figure 2. The Sca1 Complex Regulates Aggregation, Chemotaxis, and Vegetative Cell Motility
(A) Development of the different knockout strains compared to wild-type. Shown pictures were taken at 12 hr after starvation. Data are representative of three
independent experiments. See also Figure S2.
(B and C) DIAS analysis and traces of representative developed cells performing chemotaxis to cAMP (B) or randomly moving vegetative cells (C). Data represent
analysis performed on ten traces from three independent experiments ± SD. Speed refers to the speed of the cell’s centroid movement along the total path;
directionality indicates migration straightness; persistence indicates the persistence of movement in a given direction; direction change refers to the number
and frequency of turns; and roundness indicates cell polarity.
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A RasGEF Complex Controls RasC-TORC2 Signalingwith PP2A (Sca1D4–D6), as well as Sca1DCT, fail to complement
the scaA cell phenotype (Figure S2B). Unfortunately, efforts to
disrupt pppA and pho2B were unsuccessful. As another group
also reported unsuccessful attempts to disrupt pppA, we
suggest that PP2A is essential for growth (Murphy et al., 1999).
The subsequent analysis of developed, single cells revealed
that phr, gefH, gefA, scaA, and gefH/gefA display direc-
tionality defects during chemotaxis (Figure 2B; Movie S1). In
addition, we found that vegetative gefA, gefH/gefA, and
scaA cells all display defects in random motility (absence of
chemoattractant), as indicated by their reduced speed and
persistence of movement compared to wild-type cells
(Figure 2C). Intriguingly, we observed that vegetative phr cells
move considerably faster and with greater persistence than
wild-type cells. These observations suggest that the Sca1
complex regulates cell motility, chemotaxis, and also, presum-
ably, signal relay during aggregation, as cells lacking Aimless
or Sca1 do not stream (data not shown).
Since the loss of RasGEFH in the complex entails the loss of
PHR and phr cells display phenotypes distinct from those of
the other Sca1 complex null cells, it appears that PHR might
play a different role in the regulation of chemotaxis than the
other components of the Sca1 complex (see Discussion). There-
fore, we did not include further analysis of PHR in the present
study.740 Developmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier InThe Sca1 Complex Controls RasC Signaling
at the Leading Edge
To investigate the function of the Sca1 complex, we first as-
sessed the chemoattractant-mediated activation of Ras in the
different Sca1 complex null backgrounds. In Figure 3A and
Figure S3A, we show that the Sca1 complex regulates RasC
activity while RasG activation is unaffected. Chemoattractant-
induced activation of RasC is reduced in gefH cells and is
almost completely absent in gefA cells, whereas cells lacking
the two RasGEFs or Sca1 totally fail to induce RasC activation,
indicating Aimless and RasGEFH are required for RasC activa-
tion. In addition, we found that PKB activity is gradually reduced
in the different null strains, with the strongest reduction observed
in scaA, and F-actin polymerization is also reduced (Figures 3B
and 3C). Interestingly, we found that chemoattractant-induced
accumulation of cAMP is reduced in gefH cells and absent in
gefA, gefH/gefA, and scaA, in a way that correlates with
the level of RasC activity in each strain (Figure 3D). In addition,
we determined that pkb/pkbr1 cells completely fail to stimu-
late cAMP accumulation in response to chemoattractant stimu-
lation, suggesting that the two kinases might be downstream
from RasC in the pathway leading to ACA activation. Therefore,
impaired signaling to the actin cytoskeleton and ACA most likely
underlies the aggregation, cell motility, and chemotaxis defects
of the Sca1 complex null mutants. Interestingly, we also foundc.
Figure 3. The Sca1 Complex Controls the
RasC-TORC2-PKB/PKBR1 Pathway
(A) FLAG-RasC was expressed in the indicated
strains and cAMP-induced RasC activity was as-
sessed following pull-down of active RasC
(RasC-GTP) with GST-RBD(Byr2). Pulled down
and total RasC were revealed by FLAG immuno-
blotting. See also Figure S3.
(B) cAMP-induced kinase activity of immunopre-
cipitated PKB was assessed using H2B as
a substrate. H2B phosphorylation was detected
by autoradiography and PKB was revealed by
immunoblotting.
(C) Basal (inset; expressed as percentage of wild-
type) and cAMP-induced F-actin polymerization.
(D) Total cAMP production in response to stimula-
tion by 10 mM 20-deoxy-cAMP for the time indi-
cated.
(E) Imaging of PHcrac-GFP in wild-type and scaA
performing chemotaxis to cAMP.
(F) Translocation of PHcrac-GFP to the plasma
membrane upon uniform cAMP stimulation. The
graph depicts the relative fluorescence intensity
of membrane-localized PHcrac-GFP as a function
of time after cAMP stimulation. Data represent the
measured membrane fluorescence intensity of ten
different cells.
(G) cAMP-induced phosphorylation of immuno-
precipitated PKB at threonine 473 (TP473) and of
PKBR1 from total cell lysates at threonine 470
(TP470). Immunoprecipitated PKB was revealed
by immunoblotting, and Coomassie blue (CB)
staining was used as loading control for total cell
lysates. Data are representative or represent the
mean ± SD (C and D) or SEM (F) of at least three
independent experiments.
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vegetative cells is greatly reduced in scaA compared to that in
wild-type cells, suggesting that the Sca1 complex controls RasC
signaling in vegetatively growing amoebae as well as in the
developed cells (Figure S3B), consistent with random motility
defects in vegetative amoebae (Figure 2C).
To assess which Ras effector pathway contributes to the
RasC-regulated PKB activity downstream from the Sca1
complex, we first tested the chemoattractant-induced activity
of PI3K in live cells using a fluorescent PI(3,4,5)P3 reporter con-
sisting of the pleckstrin homology domain of the cytosolic regu-
lator of adenylyl cyclase fused to GFP (PHcrac-GFP) (Dormann
et al., 2002; Parent et al., 1998). As shown in Figures 3E and
3F, the production and accumulation of PI(3,4,5)P3 in scaA

cells, at both the leading edge in chemotaxing cells and
uniformly along the plasma membrane upon global chemoat-
tractant stimulation, are similar to those in wild-type cells. In
contrast, when evaluating the chemoattractant-induced activity
of TORC2 by assessing the phosphorylation of PKB and
PKBR1 at their hydrophobic motif (Kamimura et al., 2008), we
found that TORC2 activity is decreased in scaA compared to
that in wild-type cells (Figure 3G). These findings suggest that
the Sca1 complex-regulated RasC activation modulates the
activity of TORC2 and not PI3K.DeveUsing a fluorescent reporter for Ras activity [Ras binding
domain (RBD) of human Raf1 fused to GFP], which binds active
RasG but not RasC, we showed previously that active RasG
(RasG-GTP) is enriched at the leading edge of migrating cells
(Kae et al., 2004; Sasaki et al., 2004; Zhang et al., 2008).
However, the localization of active RasC remains unknown.
Therefore, to better understand the regulation of RasC’s function
by the Sca1 complex, we studied the localization of a GFP-Sca1
fusion protein, which complements the scaA phenotypes (data
not shown). As illustrated in Figure 4A, GFP-Sca1 ismostly found
in the cytosol of resting cells but a fraction is recruited to the
plasma membrane upon uniform chemoattractant stimulation,
peaking 6 s after stimulation. Interestingly, GFP-Sca1 does
not undergo chemoattractant-induced membrane translocation
in cells that lack Aimless and RasGEFH, which suggests that
the RasGEFs and/or PHR are required for the recruitment of
the complex to the plasma membrane. To investigate the mech-
anisms regulating the localization of the Sca1 complex, we as-
sessed the effect of inhibiting F-actin polymerization and PI3K
on the membrane translocation of GFP-Sca1 using Latrunculin
B (LatB) and LY294002, respectively. Whereas cells treated
with LY294002 actually displayed increased and prolonged
GFP-Sca1 translocation, LatB treatment inhibited themembrane
translocation of GFP-Sca1 (Figure 4B). Consistent with theselopmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier Inc. 741
Figure 4. Sca1 Transiently Localizes to the Plasma Membrane in a Chemoattractant- and Actin-Dependent Manner and Is Negatively Regu-
lated by TORC2
(A) Live imaging of GFP-Sca1, expressed in either scaA or gefH/gefA/scaA, upon uniform cAMP stimulation. Numbers represent time after stimulation in
seconds. The relative membrane fluorescence intensity of GFP-Sca1 is shown on the right.
(B) Cells were treated with 15 mM LatB or 60 mM LY294002 for 30 min prior cAMP stimulation.
(C) cAMP-induced RasC activity was assessed as described in Figure 3A, following LatB and LY294002 treatments. Quantification of data, expressed as
a percentage of the 10 s time point (max) for the control, is shown on the right. Data represent mean ± SD of two independent experiments.
(D) Live imaging of GFP-Sca1 expressed in wild-type (WT), piaA, or pikA/pikB/pikC cells. All imaging data represent mean ± SEM ofR25 measurements
performed onR20 cells from three independent experiments, and scale bars represent 5 mm. See also Figure S4.
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prolongschemoattractant-mediatedRasCactivation (Figure4C).
LY294002was previously suggested to inhibit TORC2 in addition
to PI3K and we observed that the inhibitor did inhibit 30%
of TORC2 activity under the conditions used for the GFP-Sca1742 Developmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier Intranslocation assay (Figure S4) (Brunn et al., 1996; Kamimura
et al., 2008). Therefore, to directly address the role of PI3K
and TORC2 in the regulation of GFP-Sca1’s localization, we
assessed the membrane translocation of GFP-Sca1 in cells
lacking either Pianissimo (TORC2 component and orthologc.
Figure 5. Sca1 Is Enriched at the Leading
Edge of Chemotaxing Cells
(A) Live imaging of LY294002-treated scaA cells
expressing GFP-Sca1 or wild-type cells express-
ing soluble GFP and migrating in an exponential
gradient of cAMP delivered by a micropipette.
Asterisk shows position of the micropipette.
(B) scaA cells expressing GFP-Sca1 or wild-type
cells expressing either the RasG-GTP reporter
(GFP-Raf1RBD) or soluble GFP and migrating
under agar in a cAMP gradient were imaged by
TIRFM. Signal from the soluble GFP had to be
intensified in order to be visualized. Arrows mark
regions of enriched fluorescence. Scale bars
represent 5 mm.
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A RasGEF Complex Controls RasC-TORC2 Signalingof mammalian Rictor) or PI3K1, 2, and 3. With the presence of
endogenous Sca1 in these strains and wild-type cells, the level
of GFP-Sca1 translocation is smaller than that in scaA;
however, we clearly observed that the membrane translocation
of GFP-Sca1 in piaA was considerably prolonged, whereas it
was slightly reduced in pikA/pikB/pikC compared to that in
wild-type cells (Figure 4D). These findings suggest that while
an intact actin cytoskeleton is required for the transient chemo-
attractant-dependent localization of the Sca1 complex at the
plasma membrane, and therefore RasC activation, TORC2
signaling plays a negative regulatory role.
Attempts to determine the localization of GFP-Sca1 in che-
motaxing cells using conventional confocal microscopy have
been unsuccessful, possibly because the amount of GFP-
Sca1 localized at the membrane compared to the cytosol at
any given time is too low to be clearly visualized. However,
cells pretreated with LY294002, which increases the cAMP-
induced GFP-Sca1 membrane translocation (Figure 4A),
exhibit an enrichment of GFP-Sca1 at the leading edge in
contrast to LY294002-treated cells expressing only GFP
(Figure 5A). To assess the localization of GFP-Sca1 during
chemotaxis under normal conditions, we turned to total
internal reflection fluorescence microscopy (TIRFM), which
provides a higher signal-to-noise ratio and allows visualization
of proteins at or near the plasma membrane only (Axelrod,
2001). Using TIRFM imaging and cells chemotaxing under
agar to insure uniformly flat cells, we confirmed that GFP-
Sca1 is periodically enriched at the plasma membrane of
extending pseudopodia and at the leading edge of chemotax-
ing cells (Figure 5B). Moreover, we observed that GFP-Sca1
displays two different patterns of membrane localization within
the protrusion: it is found either uniformly distributed or
transiently enriched in discrete regions appearing as dots
that persist for no more than 4 s at a time. In contrast, cells
expressing soluble GFP display a smooth and uniform signalDevelopmental Cell 18, 737–that could only be detected with longer
exposures. Interestingly, when assessed
in TIRFM, the RasG activity reporter
GFP-Raf1RBD revealed membrane
localization patterns similar to those of
GFP-Sca1 (Figure 5B). These findings
suggest that the Sca1 complexpromotes RasC activation at the leading edge of chemotaxing
cells in regions similar to those of enriched RasG-GTP.TORC2 and PKB/PKBR1 Regulate RasC Activity Via
Negative Feedback
The presence of PP2A in the Sca1 complex suggests that the
complex’s function is tightly regulated by phosphorylation. We
performed phosphoproteomic studies on samples from unsti-
mulated cells and cells stimulated with chemoattractant for
either 10 or 60 s and found that Sca1 undergoes dynamic phos-
phorylation. One phosphorylation site in particular (S359),
detected only at 10 s after stimulation, is within a PKB phosphor-
ylation consensus motif (RXRXXS/T; Alessi et al., 1996)
(Figure 6A). We then analyzed the PKB phosphorylation of immu-
nopurified Sca1 by western blot, using an anti-phospho-PKB
substrate antibody (aP-PKBS). As shown in Figure 6B, the
PKBS antibody allows detection of transient chemoattractant-
induced phosphorylation of Sca1, with a peak at 5–10 s after
stimulation, which correlates with the phosphoproteomics
data. Furthermore, we found that this Sca1 phosphorylation is
reduced in cells lacking PKB (pkbA), reduced to a greater
extent in pkbr1 cells, and abolished in cells lacking both kinases
(Figure 6C). Our findings suggest that Sca1 undergoes chemoat-
tractant-regulated PKB/PKBR1-mediated phosphorylation. We
further found that Sca1 is not phosphorylated in piaA cells, sug-
gesting TORC2 is required for this response (data not shown).
Given that PKB/PKBR1 mediates cAMP production, and conse-
quently lies upstream from PKA, we assessed whether part of
the phosphorylation signal is PKA dependent. Unexpectedly,
we found that both the basal and chemoattractant-induced
phosphorylation of Sca1 are increased in PKA catalytic null
cells (pkaC) compared to that in wild-type cells (Figure 6C).
Therefore, these observations suggest that whereas the
PKB/PKBR1-dependent phosphorylation of Sca1 occurs749, May 18, 2010 ª2010 Elsevier Inc. 743
Figure 6. The Function of the Sca1 Complex Is Regulated by TORC2 and PKB/PKBR1 in a Negative Feedback Fashion and by PP2A
(A) Phosphoproteomics analysis allowed identification of Sca1 phosphorylation at serine 359 (S359). Two spectra corresponding to the indicated phosphopep-
tide were obtained from a sample stimulated for 10 s with cAMP.
(B and C) cAMP-induced phosphorylation of immunoprecipitated myc-tagged Sca1 expressed in the indicated strains was assessed by immunoblotting with an
anti-phospho-Akt/PKB substrate antibody (aP-PKBS).
(D and E) cAMP-induced RasC activity in the indicated strains was assessed as described in Figure 3A. Expression of HHF-Sca1 and -Sca1D5 was controlled by
HA immunoblotting.
(F) cAMP-induced PKB kinase activity was assessed as described in Figure 3B.
(G) Live imaging of GFP-Sca1D5 upon uniform cAMP stimulation. Numbers represent time after stimulation in seconds. Scale bar represents 5 mm. Data are
representative of at least two independent experiments.
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A RasGEF Complex Controls RasC-TORC2 Signalingindependently of PKA, PKA is involved in the regulation of this
pathway.
Since the Sca1-controlled RasC activity promotes the activa-
tion of PKB/PKBR1 through regulation of TORC2, PKB/PKBR1-
mediated phosphorylation of Sca1 suggests the presence of
a regulatory feedback mechanism. To investigate this possible
feedback loop, we assessed the activation of RasC in744 Developmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier InpkbA/pkbr1 and piaA cells. Surprisingly, we found that not
only is the basal level of RasC activity elevated in both
pkbA/pkbr1 and piaA compared to that in wild-type cells
but also that chemoattractant-induced RasC activation is
considerably increased and fails to rapidly adapt as it normally
does by 40 s after stimulation (Figure 6D). Consequently, these
findings suggest that TORC2 and PKB/PKBR1 regulate RasCc.
Figure 7. Regulation of RasC Signaling during
Chemotaxis
Chemoattractant stimulation promotes the F-actin-
dependent recruitment of the Sca1 complex to the plasma
membrane and the subsequent activation of the RasC-
TORC2-PKB/PKBR1 pathway at the leading edge of
chemotaxing cells. This signaling pathway controls
cAMP production and leads to modulation of the F-actin
cytoskeleton, thereby regulating signal relay and cell
motility, respectively. The RasG-PI3K pathway appears
to regulate F-actin, ACA (via CRAC), and PKB indepen-
dently of the RasC-TORC2 pathway, and other regulators
and/or Ras proteins control TORC2 activity in addition to
RasC. It is also possible that RasC has other effectors.
TORC2 and PKB/PKBR1 regulate RasC activity in a nega-
tive feedback fashion that involves regulation of the Sca1
complex’s localization through phosphorylation of Sca1.
PP2A seems to be necessary for the function of the
Sca1 complex, possibly for the dynamic regulation of the
complex by phosphorylation.
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A RasGEF Complex Controls RasC-TORC2 Signalingactivation in a negative feedback fashion, which might involve
direct regulation of the Sca1 complex by PKB/PKBR1.
To obtain insight into the role of PP2A in the Sca1 complex, we
used the Sca1 deletion mutant Sca1D5 that disrupts the interac-
tion of the scaffold with PP2A but still associates with the
RasGEFs and PHR (Figures 1I and 1J and Figure S1B).
Sca1D5 fails to rescue the chemoattractant-induced activation
of RasC and PKB in scaA and does not translocate to the
plasma membrane upon uniform chemoattractant stimulation
(Figures 6E–6G). These observations suggest that PP2A is
essential for the function of the Sca1 complex, possibly by
controlling its translocation to the cortex.
DISCUSSION
Significant progress has been made toward identifying genes
implicated in chemotaxis, but little is known about the molecular
mechanisms that spatiotemporally control chemotactic
signaling. Our study sheds light on one of these mechanisms
that involves the identified Sca1/RasGEF/PP2A signaling
complex, which controls the RasC-TORC2-PKB/PKBR1
pathway at the leading edge of chemotaxing cells, and reveals
that RasC signaling is tightly controlled through TORC2- and
PKB/PKBR1-mediated negative feedback regulation (Figure 7).
Our pull-down and coimmunoprecipitation experiments
suggest that Aimless, RasGEFH, and Sca1 form a single, stable
complex that also includes PHR and the PP2A core enzyme
PP2A-A/C2. These experiments, together with Sca1’s lack of
a known enzymatic domain, strongly suggest that Sca1 is a scaf-
folding protein. Although Sca1 does not appear to be
evolutionarily conserved, we found that the Dictyostelium
genome encodes a Sca1-related protein, designated Sca2
(DDB_G0267776). Interestingly, we have preliminary data sug-
gesting that Sca2 also associates with two LisH domain-contain-
ing RasGEFs, RasGEF-F and RasGEFI (Wilkins et al., 2005), as
well as the PP2A-A/C2 core enzyme (S. Lee, P.G.C., and
R.A.F., unpublished data). We do not yet know which RasDeveproteins are regulated by RasGEF-F andRasGEFI, but it appears
that the Sca2 complex regulates different cellular functions than
those controlled by the Sca1 complex. Thus, the existence of
RasGEF-containing complexes extends beyond the Sca1
complex described here, although its presence in other organ-
isms is unknown. It is possible that, even if Sca1 and Sca2 are
not conserved outside of Dictyostelium, their functions are. It is
interesting that no PP2A regulatory B subunits were found
associated with the Sca1 complex under either unstimulated or
stimulated conditions (data not shown). It is possible that the
interaction of the regulatory B subunit with the core PP2A dimer
in the Sca1 complex is too weak and/or transient to allow its
detection in our pull-down experiments.
The developmental, chemotaxis, and random cell motility
phenotypes of gefA, gefH/gefA, and scaA are extremely
similar to those of rasC, which is consistent with the primary
role of the Sca1 complex in promoting RasC activation (Lim
et al., 2001, 2005). In addition, our data indicate that most of
the Sca1 complex’s GEF activity toward RasC is provided by
Aimless, but RasGEFH also plays a role. Indeed, we repeatedly
observed that chemoattractant-induced RasC activation is
reduced in gefH, and we sometimes observed residual RasC
activation in gefA, which is then lost in gefH/gefA. These
observations suggest that RasGEFH is essential for full activa-
tion of RasC by Aimless and may have some GEF activity
toward RasC. Whether RasGEFH interacts with another LisH
domain-containing RasGEF, or complex, in the absence of
Aimless is unknown. It is also unclear whether RasGEFH and
PHR always interact and what role PHR plays in the complex.
However, the fact that the phenotypes of phr cells differ from
those of gefH, while PHR associates with the Sca1 complex
by interacting with RasGEFH, suggests that PHR might have
a separate function in addition to that linked to the Sca1
complex. Alternatively, PHR might play an intricate regulatory
role in the Sca1 complex’s function, which does not require
direct interaction with the complex. We are currently investi-
gating these possibilities.lopmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier Inc. 745
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A RasGEF Complex Controls RasC-TORC2 SignalingAs was previously suggested for Aimless (Insall et al., 1996),
we found that the Sca1 complex controls both F-actin polymer-
ization and cAMP production (signal relay), which explains the
cell motility and aggregation defects of the Sca1 complex null
mutants. However, whereas cAMP accumulation correlates
with the level of RasC activity in Sca1 complex null cells, consid-
erable levels of TORC2 and PKB activity remain in cells lacking
gefA or scaA, which suggest that the Sca1 complex-regulated
RasC activity only controls part of the chemoattractant-induced
TORC2 and PKB activation. Interestingly, we found that
PKB/PKBR1 is essential for the chemoattractant-induced accu-
mulation of cAMP and that the Sca1 complex-regulated RasC
activity controls PKB, and most likely also PKBR1, by regulating
TORC2 and not PI3K. Whereas data suggest that PKBR1 is
regulated solely by TORC2 and not PI(3,4,5)P3 signaling, PKB
is regulated by both (Kamimura et al., 2008; Lee et al., 2005; Meili
et al., 1999, 2000). Thus, PKB activity seems to be controlled by
at least two parallel Ras pathways: a RasG-PI3K and a RasC-
TORC2 pathway (Figure 7). Given our previous finding that the
homolog of the human TORC2 component Sin1, RIP3, interacts
with RasG in vitro, perhaps RasG, in addition to controlling PI3K,
also controls TORC2 activity in vivo (Lee et al., 1999). We previ-
ously suggested that RIP3 did not bind to RasC in yeast two-
hybrid assays; however, more recent studies suggest that this
may have been due to a very poor expression of RasC in this
yeast two-hybrid system (data not shown). Because some
TORC2 activity was reported to remain in rasC/rasG cells,
TORC2 also appears to have other, yet unknown, upstream regu-
lators (Kamimura et al., 2008). Altogether, these observations
indicate that TORC2 and PKB/PKBR1 are important signal inte-
grators, coordinating cell motility and chemotaxiswith signal relay
during aggregation. The Sca1 complex-mediated RasC activa-
tion thus provides a common link between these chemoattractant
responses that must be coordinated for efficient aggregation.
The absence of chemoattractant-induced RasC activity in
scaA cells suggests that the integrity of the Sca1 complex is
crucial and controls the function of the associated RasGEFs.
Intriguingly, whereas chemoattractant-induced RasC activity is
absent in both gefH/gefA and scaA, we consistently
observed that PKB’s activity is lower in scaA than that in
gefH/gefA. Although this discrepancy could simply be due
to a difference in sensitivity between the assays, it is also
possible that Sca1 interacts with other RasGEFs in the absence
of Aimless, leading to some Sca1-dependent regulation of PKB
activity through activation of a Ras protein other than RasC, in
gefA and gefH/gefA, which is then lost upon disruption of
scaA. In support of this hypothesis, we found that some Ras-
GEF-F copurifies with Sca1 when Sca1 is expressed in
gefH/gefA/scaA, although very little RasGEF-F is detected
in this pull-down compared to the amount of Aimless and Ras-
GEFH usually copurified with Sca1 (data not shown).
The relatively weak enrichment of Sca1 to the plasma
membrane upon uniform chemoattractant stimulation and to
the leading edge of migrating cells is consistent with Ras activa-
tion being very upstream in the chemoattractant signaling path-
ways, which is thought to occur immediately downstream from
the receptors and heterotrimeric G proteins and prior to signal
amplification. Using LY294002-treated cells as well as TIRFM
imaging, we were able to see that Sca1 is enriched at the leading746 Developmental Cell 18, 737–749, May 18, 2010 ª2010 Elsevier Inedge membrane of chemotaxing cells and to sites similar to
those of a RasG-GTP reporter. Previously, with the lack of
in vivo reporter for RasC activity, the general assumption was
that RasC-GTP must localize at the back of migrating cells,
where ACA is enriched (Kriebel et al., 2003, 2008). However,
the findings that the Sca1 complex is enriched at the leading
edge and that RasC regulates TORC2, whose activity was
recently suggested to be restricted to the leading edge
(Kamimura et al., 2008), strongly support that RasC-GTP also
localizes to the front of chemotaxing cells. As we also found
that PKB/PKBR1 is necessary for ACA activation, we suggest
that a soluble PKB/PKBR1 substrate is implicated in linking the
RasC-TORC2-PKB/PKBR1 pathway to the activation of ACA.
The mechanism by which the Sca1 complex is recruited to the
plasmamembrane upon chemoattractant stimulation remains to
be determined; however, our findings suggest that translocation
of the complex requires the RasGEFs and/or PHR, as well as an
intact actin cytoskeleton, and is negatively regulated in
a TORC2-PKB/PKBR1-dependent fashion, most likely impli-
cating direct PKB/PKBR1 phosphorylation of Sca1. We are
currently investigating potential PHR-, Aimless-, and Ras-
GEFH-interacting proteins that might act in the recruitment of
Sca1 to the plasma membrane and promote activation of the
RasGEFs. One possibility is that the RasGEFs directly interact
with the activated heterotrimeric G proteins. The role of the actin
cytoskeleton in themembrane translocation of Sca1 is unknown,
but, considering the fast kinetics of the recruitment, we suggest
that the membrane recruitment of Sca1 requires an originally
intact actin cortex rather than the chemoattractant-induced F-
actin polymerization. In addition, our data suggest that TORC2
and PKB/PKBR1 regulate the activity of RasC in a negative feed-
back fashion bymodulating the localization of the Sca1 complex.
Most likely, this includes direct phosphorylation of Sca1 by PKB/
PKBR1 and requires TORC2 function but appears to be indepen-
dent of PI3K signaling. Since PI3K is upstream of PKB and not
PKBR1 (Kamimura et al., 2008; Lee et al., 2005; Meili et al.,
1999, 2000), these observations suggest that PKBR1 might
have a prominent role in the feedback regulation of RasC activity,
as well as the possibility of compartmentalization of the RasC-
TORC2-PKB/PKBR1 pathway, consistent with the relative effect
of PKB/PKBR1 knockouts on Sca1 phosphorylation.
We found that Sca1 is phosphorylated by PKB/PKBR1 at
S359. However, site-directed mutagenesis studies suggest the
presence of additional PKB phosphorylation sites in Sca1, which
remain to be identified (data not shown). Hence, regulation of the
Sca1 complex by PKB/PKBR1 may be considerably more intri-
cate. Also, in addition to regulating the Sca1 complex, TORC2
and PKB/PKBR1 might act at multiple levels of the pathway
upstream of RasC in order to efficiently attenuate RasC activity.
Moreover, we found evidence that PKA negatively regulates the
PKB/PKBR1-dependent phosphorylation of Sca1. We are
currently investigating the mechanism underlying the regulation
of Sca1 phosphorylation by PKA, but preliminary data suggest
that it occurs independently of ACA, which is consistent with
previously reported observations that ACA is not required to
provide intracellular cAMP for PKA activation (Pitt et al., 1993;
Kim et al., 1998).
Scaffold-mediated assembly of multiprotein complexes has
been implicated in the control of mitogen-activated proteinc.
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A RasGEF Complex Controls RasC-TORC2 Signaling(MAP) kinases as well as cAMP signaling pathways in mamma-
lian cells (Brown and Sacks, 2009; Carnegie et al., 2009). Studies
performed in different biological systems have shown that scaf-
folds exert substantial spatiotemporal control of MAP kinase
signaling, thereby influencing the kinase selectivity toward
substrates and determining the biological outcome (Casar
et al., 2009; Claperon and Therrien, 2007). Whether the Sca1
complex provides specificity in addition to spatiotemporal
control of RasC signaling remains to be determined. However,
many aspects of the Sca1 complex are reminiscent of the well-
described MAP kinase scaffold kinase suppressor of Ras 1
(KSR1). KSR1 associates with PP2A, which is necessary for
the KSR1-mediated activation of the ERK1/2 pathway, and
KSR1’s membrane localization and function are regulated by
ERK-mediated negative feedback phosphorylation (McKay
et al., 2009; Ory et al., 2003). Our observations suggest that
the presence of PP2A in the Sca1 complex is essential to the
complex’s function and might regulate the localization of the
complex. Further investigation is needed to fully understand
the role of the phosphatase in the Sca1 complex, but PP2A
may have a role similar to that in the KSR1 complex, promoting
its resensitization through dephosphorylation of the scaffold.
In conclusion, our study uncovered a mechanism by which
RasC and TORC2 are activated downstream from the receptor
and heterotrimeric G protein and spatiotemporally controlled
during chemotaxis. Our findings reveal that TORC2 and PKB/
PKBR1 are part of an important adaptation mechanism control-
ling RasC signaling and signal relay, which is likely to play
a central role in the global adaptation of cells that is essential
to maintain responsiveness to the chemoattractant. The Sca1
complex RasC-TORC2-PKB/PKBR1 pathway functions biologi-
cally to regulate cell motility, chemotaxis, and the relay of the
cAMP chemoattractant signal in Dictyostelium cells. The role
and regulation of TORC2 is not yet understood in any system
and, although aspects of this pathwaymay be unique toDictyos-
telium, we suggest that our results may also provide general
insights into how Ras and TORC2 pathways are spatially and
temporally controlled downstream from G protein-coupled
receptors in other systems.EXPERIMENTAL PROCEDURES
Affinity Purification
For pull-down and coimmunoprecipitation assays, 108 cells were lysed in 1 ml
HEPES-DSP lysis buffer [50 mM HEPES (pH 7.2), 0.5% NP-40, 150 mM NaCl,
10% glycerol, and 2 mM DSP, with phosphatase and protease inhibitors
(10 mM NaF, 1 mM sodium-orthovanadate, 25 mM b-glycerophosphate,
3 mM sodium-pyrophosphate, 1 mM PMSF, 5 mg/ml leupeptin, and 5 mg/ml
aprotinin)], followed by quenching of the crosslinker with 150 mM Tris
(pH 7.4). For simple immunoprecipitation, cells were lysed in Tris lysis buffer
[50 mM Tris (pH 7.6), 1% NP-40, 100 mM NaCl, 1 mM EDTA, 10% glycerol,
and 1 mM DTT, with phosphatase and protease inhibitors]. For cAMP-stimu-
lated samples, cells were lysed with 23 lysis buffer at the indicated time after
stimulation with 1 mM cAMP and cleared by centrifugation. Samples were then
subjected to sequential FLAG-His purification (pull-downs) and analyzed by
mass spectrometry or immunopurified with the indicated agarose-coupled
antibodies, resolved on SDS-PAGE, and analyzed by western blot.
Mass Spectrometry and Phosphopeptide Analysis
Analysis of the protein samples by mass spectrometry was performed as
described previously (Para et al., 2009). For the phosphoproteomics assay,Deve4 3 108 developed cells were washed, resuspended in 20 mM MES
(pH 6.8), and then stimulated for either 10 or 60 s with 10 mM cAMP, and the
stimulations were stopped by adding an equal volume of cold 23 HBS buffer
[20 mM HEPES (pH 7.4), 300 mM NaCl, 4% RapiGest (Waters), 0.4 mM
sodium-orthovanadate, 10 mM b-glycerophosphate, 4 mM NaF, and
1.2mM sodium-pyrophosphate] and plunging the samples in lN2. The samples
were then thawed on ice and solubilized by sonication. Protein samples were
diluted four times with 25 mM HEPES buffer (pH 7.2) and 10 mg of protein/
sample was reduced, alkylated, and digested with trypsin. The samples
were incubated with 1% TFA (pH 1.4) for 16 hr at 4C to precipitate RapiGest
and cleared by filtration. Phosphopeptides were enriched using homemade
TiO2 columns and acidified prior to LC-MS/MS analysis.
Biochemical Assays
Chemoattractant-induced production of cAMP, Ras activity, PKB kinase
activity, and F-actin measurements were performed as described previously
(Insall et al., 1996; Meili et al., 1999; Sasaki et al., 2004, 2007; Van Haastert,
2006; Zhang et al., 2008). We assessed TORC2 activity by evaluating the
TORC2-mediated phosphorylation of PKB and PKBR1. Briefly, 108 aggrega-
tion-competent cells were washed and desensitized for 20 min in 12 mM
sodium/potassium phosphate buffer before cAMP stimulation. We immuno-
precipitated PKB while using total cell lysates to assess PKBR1 phosphoryla-
tion. The samples were resolved on SDS-PAGE and phosphorylation of
the kinases’ hydrophobic motif was detected using anti-phospho-(Ser/Thr)
PDK1 docking motif (18A2) as described previously (Kamimura et al., 2008).
cAMP and folate were both used at 1 mM final concentration.
Chemotaxis, Global Responses, and Cell Motility Assays
Assessment of chemotaxis, global responses to cAMP, and vegetative cell
motility, as well as analysis using the DIAS software, have been described
elsewhere (Chung and Firtel, 1999; Sasaki et al., 2007; Wessels and Soll,
1998). We performed chemotaxis under agar as previously described (Andrew
and Insall, 2007). Image acquisition and analysis were performed as described
previously (Zhang et al., 2008).
Additional procedures, including the cell culture and molecular biology
methods, as well as a list of reagents, can be found in the Supplemental
Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental information includes four figures, one table, one movie, Supple-
mental Experimental Procedures, and Supplemental References and can be
found with this article online at doi:10.1016/j.devcel.2010.03.017.
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